Clinical Trials Browser

Dosage Forms × Lymphoid × 1 year × Clear all

NCT04345718 2025-12-09

EXHITENTRE

Phase 2/3 Completed

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT03593187 2025-11-20

GENHIV

Phase 1/2 Completed

Lymphoma